According to recent research from Johns Hopkins Medicine, when it comes to making choices on appropriate antibiotic prescribing, outpatient providers are making the decision based on patient demand, not necessarily on what's actually appropriate for the condition.
The FDA has permitted marketing for a new use of the BRUKER MALDI Biotyper CA system to identify Candida auris.
Previously seen in Wisconsin in 2015-2016, Elizabethkingia seems to have made its way to the Empire state.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
A recent survey explores prevention practices for Legionnaires’ disease and water management programs in health care facilities.
Dr. Thomas Sandora shares recent data on screening for asymptomatic carriage of Clostridium difficile and provides insight into what the preferred first-line treatment for the infection in children.
Kari Simonsen, MD, and Matthew Linam, MD debate the best way to measure and improve hand hygiene compliance.
In the SHEA Spring 2018 Opening Plenary, Zintars Beldavs stresses the importance of communication and collaboration in the fight against antimicrobial resistance.
Researchers compare CLABSIs attributed to CRE in short-term acute care hospitals with long-term acute care hospitals using data reported to NHSN in 2015-2016.
PIV infections are not as rigorously studied as CLABSIs, but they should be.
Women living with HIV are at elevated risk for comorbidities as their life expectancy increases.
Infections associated with the ongoing opioid epidemic in the United States apparently know no bounds.
In a recent webinar, epidemiologists from the Centers for Disease Control and Prevention presented data on Rocky Mountain Spotted Fever ahead of the summer tick season.
About 1.6 million individuals die from violence each year on a global scale—do infectious disease physicians have a role in preventing it?
Health officials are investigating an outbreak of Salmonella Braenderup infections linked to shell eggs from Rose Acre Farms’ Hyde County Farm.
Researchers have identified the OX40 pathway as playing a key role in viral clearance.
How can we improve infection control in such a tricky environment?
In case you missed them, we’ve compiled a list of the latest recalls posted this week.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Contagion® will be covering the conference, and so, keep a look out for session coverage as well as interviews with some of the key presenters.
The Centers for Disease Control and Prevention (CDC) announced an investigation into a multistate outbreak of E. coli O157:H7 infections, now impacting 7 states.
Invasive meningococcal disease doesn’t always present with the classic symptoms of stiff neck and headache—for a small subset of IMD patients, the abdomen is where the disease shows itself.
New strains of the mumps virus are not to blame for the recent resurgence of cases, say researchers in a new study, instead pinning the recent outbreaks on declining protective effects of the mumps vaccine over time.
Organ donor recipients taking anti-rejection medications are at risk for infection, but a new study has found that the rate of death from such infections has declined significantly.
The contaminated chicken salad has sickened over 260 individuals in 8 states and claimed 1 life.
In an era of in which everything is political—and politics is perhaps more polarized than ever before—Dr. Adams is advocating for what APHA Executive Director Georges Benjamin, MD, described as the “sensible middle.”
A rare cholera outbreak on Vancouver Island, Canada has been linked with the consumption of herring eggs.
One dose of microbiota-based therapy proved more effective than 2 at wiping out recurrent C. difficile infection.
On National Youth HIV/AIDS Awareness Day we take a closer look at how the HIV/AIDS epidemic impacts younger individuals and what can be done to cut back on new diagnoses.
Representatives from Novavax, Inc., an American-based biotechnology company, presented data at the recent World Vaccine Congress in Washington, DC, on their vaccines under development for the flu and RSV.
